Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023

Rhea-AI Summary

Exscientia plc (Nasdaq: EXAI) will report financial results for the second quarter ended June 30, 2023, on August 10, 2023, before the open of U.S. markets. The company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to provide a business update and review financial results. The webcast can be accessed on the company's website, and the conference call can be accessed by phone. A replay will be available on the website for 90 days.

Company to host conference call and webcast on August 10, 2023, at 1:30 p.m. BST / 8:30 a.m. EDT

OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) will report financial results for the second quarter ended June 30, 2023, on Thursday August 10, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to provide a business update and review financial results.

A webcast of the live call can be accessed by visiting the “Investors and Media” section of the Company’s website at investors.exscientia.ai. Alternatively, the live conference call can be accessed by dialing +1 (888) 330 3292 (U.S.), +44 203 433 3846 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895. A replay will be available for 90 days under "Events and Presentations” in the “Investors and Media” section of the Exscientia website.

About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

Visit us at https://www.exscientia.ai or follow us on Twitter @exscientiaAI.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230803180816/en/

Investor Relations:

Sara Sherman

investors@exscientia.ai



Media:

Oliver Stohlmann

media@exscientia.ai

Source: Exscientia

FAQ

When will Exscientia plc report its financial results for the second quarter of 2023?

Exscientia plc will report its financial results for the second quarter of 2023 on August 10, 2023, before the open of U.S. markets.

What time will the conference call and webcast be held?

The conference call and webcast will be held at 1:30 p.m. BST / 8:30 a.m. EDT.

Where can I access the webcast?

The webcast can be accessed by visiting the 'Investors and Media' section of the Exscientia website at investors.exscientia.ai.

How can I access the conference call?

The conference call can be accessed by dialing +1 (888) 330 3292 (U.S.), +44 203 433 3846 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895.

Will there be a replay of the conference call and webcast?

Yes, a replay will be available for 90 days under 'Events and Presentations' in the 'Investors and Media' section of the Exscientia website.